Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're researching semaglutide payment plans, the direct answer is this: in the UK, semaglutide for weight loss is a prescription-only medicine, so any payment arrangement covers a private clinical service — consultation, prescription and dispensing — not a consumer product you can split into instalments. Most regulated online pharmacies and private clinics charge per treatment cycle, typically monthly, meaning each order is a separate transaction rather than a credit agreement. What that actually costs, what's included, and how to tell a safe arrangement from a risky one are the things worth understanding before you start. As with any prescription medicine, a prescriber decides whether semaglutide is clinically appropriate for you specifically; payment structure follows from that clinical decision, not the other way around.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The phrase 'payment plan' means something different when it applies to a prescription medicine. With most consumer goods a payment plan spreads a known total cost over time through a credit agreement. With semaglutide, the structure is different: you pay per treatment cycle, usually four weeks, because the prescriber must review your progress before each repeat. That review isn't a formality, it's what makes the arrangement legal and safe.
This matters for budgeting. A single quoted monthly price can look straightforward, but the number you see is often for one pen at one dose. Because the semaglutide titration schedule works in steps (lower doses first, higher doses later) your cost per cycle will change over the course of treatment. Providers who show a single price without specifying which dose it covers can make comparison genuinely difficult.
Before committing to any provider, ask what the full price per dose tier is, what's included (consultation? prescription fee? delivery?), and what happens if your dose needs to change. The cost context around Wegovy in the UK is worth reading if you want a broader picture of how private pricing has shifted since 2025. Worth checking: NHS guidance notes that Wegovy is a prescription medicine requiring clinical assessment, and the NHS semaglutide page is a useful reference for understanding what the medicine is before you think about cost.
Semaglutide for weight management starts at 0.25 mg and moves through 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg, with the prescriber guiding each increase roughly every four weeks. The 7.2 mg single-dose pen, approved by the MHRA in April 2026, sits above that as the current maximum. Each dose step is a different pen, and private providers price each pen separately.
What this means in practice: your first four weeks cost X, but month four or five (when you may be at a higher dose) costs more. Anyone building a budget should map the full schedule, not just the starter price. Some providers advertise the lowest-dose pen prominently; others show the maintenance-dose price. Neither is dishonest in isolation, but comparing them directly without knowing which dose you're looking at produces a misleading number.
If you're already on treatment and considering Wegovy treatment options through a regulated provider, bring evidence of your current dose, a legitimate prescriber will ask to see it before approving a continuation or dose increase. Our clinical team reviews this as standard, and if you've noticed side effects such as belching while taking Wegovy, that's worth raising at your next review too. That safeguard protects you; it also means a responsible provider can't offer instant sign-up at any dose without clinical grounds.
A legitimate private arrangement for semaglutide covers four things in one price: clinical consultation, prescription, the medicine itself and delivery. If any of those four is listed as an add-on, or is simply absent from the description, the headline figure isn't the real cost. At nume, one transparent price covers the consultation, our prescriber's review, the treatment and free next-working-day tracked delivery, no subscription, no auto-renewal, and every repeat order is reviewed by a GPhC-registered Independent Prescriber before it goes out. You'll get a DPD tracking notification, and the pen arrives in plain, unbranded packaging.
Red flags in private semaglutide pricing are worth knowing. Sellers who offer semaglutide without asking for a consultation, who apply discount codes to prescription medicines, or whose prices sit well below the established private market are not operating within the normal regulated framework. The MHRA has warned explicitly about counterfeit weight-loss pens circulating online; reporting anything suspicious via the Yellow Card scheme helps protect other patients. Low price is the wrong test for a prescription medicine, clinical legitimacy is the right one.
For a fuller look at how Wegovy is structured as a treatment, the Wegovy overview covers the licensed indication, dose schedule and what clinical trial evidence showed. If you have questions about ongoing support, our FAQs address the most common ones, and our contact page connects you with the aftercare team directly.
Semaglutide (Wegovy) is recommended by NICE for weight management under TA875, but the NHS route requires treatment within a specialist weight management service, for a maximum of two years, and waiting lists in many areas are long. The criteria are specific: a BMI of 35 or above (lower for some ethnic backgrounds) plus at least one weight-related condition, within a multidisciplinary programme. Many people who are clinically suitable don't yet meet the NHS threshold, or can't access a service locally without a significant wait.
Private treatment through a regulated online pharmacy fills that gap, but it comes at a cost you fund yourself. Understanding what that cost genuinely includes (and what a realistic multi-month budget looks like across the full dose schedule) is a more useful frame than looking for the lowest entry price. The Wegovy plan page outlines what a treatment course typically involves from a practical standpoint, including what to expect at each stage. For a broader look at weight-loss treatment options, our treatment overview sets out what's licensed in the UK and how private and NHS routes differ. When you're ready to have a prescriber assess your suitability, a free consultation is the place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.